Synergistic interaction of fatty acids and oxysterols impairs mitochondrial function and limits liver adaptation during nafld progression

Redox Biol. 2018 May:15:86-96. doi: 10.1016/j.redox.2017.11.016. Epub 2017 Dec 5.

Abstract

The complete mechanism accounting for the progression from simple steatosis to steatohepatitis in nonalcoholic fatty liver disease (NAFLD) has not been elucidated. Lipotoxicity refers to cellular injury caused by hepatic free fatty acids (FFAs) and cholesterol accumulation. Excess cholesterol autoxidizes to oxysterols during oxidative stress conditions. We hypothesize that interaction of FAs and cholesterol derivatives may primarily impair mitochondrial function and affect biogenesis adaptation during NAFLD progression. We demonstrated that the accumulation of specific non-enzymatic oxysterols in the liver of animals fed high-fat+high-cholesterol diet induces mitochondrial damage and depletion of proteins of the respiratory chain complexes. When tested in vitro, 5α-cholestane-3β,5,6β-triol (triol) combined to FFAs was able to reduce respiration in isolated liver mitochondria, induced apoptosis in primary hepatocytes, and down-regulated transcription factors involved in mitochondrial biogenesis. Finally, a lower protein content in the mitochondrial respiratory chain complexes was observed in human non-alcoholic steatohepatitis. In conclusion, hepatic accumulation of FFAs and non-enzymatic oxysterols synergistically facilitates development and progression of NAFLD by impairing mitochondrial function, energy balance and biogenesis adaptation to chronic injury.

Keywords: Cholesterol excess; Fatty acids; Mitochondria; Non-alcoholic fatty liver disease; Oxysterols.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / genetics
  • Diet, High-Fat
  • Disease Progression
  • Fatty Acids / adverse effects
  • Fatty Acids / metabolism*
  • Hepatocytes / metabolism
  • Hepatocytes / pathology
  • Humans
  • Lipid Metabolism
  • Liver / metabolism*
  • Liver / pathology
  • Mitochondria, Liver / metabolism
  • Mitochondria, Liver / pathology
  • Non-alcoholic Fatty Liver Disease / genetics
  • Non-alcoholic Fatty Liver Disease / metabolism*
  • Non-alcoholic Fatty Liver Disease / pathology
  • Oxidation-Reduction
  • Oxidative Stress / genetics
  • Oxysterols / adverse effects
  • Oxysterols / metabolism*
  • Reactive Oxygen Species / metabolism

Substances

  • Fatty Acids
  • Oxysterols
  • Reactive Oxygen Species